THE MARK FOUNDATION FOR CANCER RESEARCH (US) LTD
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$105,459,714
Receivables (Non-Related)
66%
Investments
28%
Cash & Equivalents
5%
Other Assets
1%
Prepaid Expenses
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$13,019,944
Grants Payable
89%
Other Liabilities
7%
Payables & Accruals
4%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$22,361,365
$5,362,621
-76%
Receivables (Non-Related)
$65,402,805
$69,262,764
+6%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$136,382
$181,430
+33%
Investments
$14,916,600
$29,409,046
+97%
Property, Plant, & Equipment (net)
$95,170
$53,431
-44%
Other Assets
$1,580,066
$1,190,422
-25%
Total Assets
$104,492,388
$105,459,714
+1%
Liabilities
2023
2024
Change
Payables & Accruals
$625,207
$508,742
-19%
Grants Payable
$18,102,751
$11,578,247
-36%
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$1,287,461
$932,955
-28%
Total Liabilities
$20,015,419
$13,019,944
-35%
Net assets
2023
2024
Change
Restricted Net Assets
$3,623,066
$8,701,440
+140%
Unrestricted Net Assets
$80,853,903
$83,738,330
+4%
Net assets
2023
2024
Change
Net assets
+$84,476,969
+$92,439,770
+9%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)